Endocrinology: Improving Outcomes in Diabetes (CPD)

25th January 2022 Virtual


Join Dr Siva Sivappriyan, Consultant Endocrinologist at One Ashford Hospital for an interactive seminar on Tuesday 25th January 2022 on Improving Outcomes in Diabetes.


Diabetes care needs to change to accommodate new evidence, improve cardiovascular and renal outcomes, the patients and also weight loss. The audience will study the new evidence on GLP 1 agonist / SGLT2 inhibitors and how to introduce them, by revising the traditional treatment.


Dr Sivappriyan will also discuss ABCDE which is the approach of providing comprehensive care in diabetes.


This is an interactive learning session and we encourage you to ask questions throughout the session. You are welcome to bring your own case studies for discussion.


The event will be held virtually, from 7:00pm – 8:00pm on Tuesday 25th January and you will be sent an invite with joining instructions 24 hours prior to the event.  Following the event, a link from Survey Monkey will be sent to you where we would appreciate your feedback. You will receive your certificate and lecture slides (if permitted by the Consultant).


To reserve a place, please click on the link below




*The event is open to all healthcare professionals with an interest in Diabetes*


Dr Sivappriyan is a Consultant Endocrinologist at Maidstone and Tunbridge wells NHS Trust. He is the clinical lead for the department and lead physician at Maidstone Hospital. He is also the college tutor and actively involved in medical education, including the local medical school development. He has a passion for clinical teaching, and is the Quality Improvement project lead for medical students from King College Hospital where he is also an Honorary Senior Lecturer at King College London.  


He provides comprehensive care in all aspects of diabetes and endocrinology. He also has special interests in obesity-related metabolic complications, rarer forms of diabetes (LADA, MODY) and hypoglycaemia. He is actively involved in clinical research, including the multicentral trials on atypical forms of diabetes and diabetes treatment in special groups. His recent work on looking at what we do with our existing and new diabetes patients has gained a lot of attention. 

Book a Place